You have 9 free searches left this month | for more free features.

Advanced Renal Cell Carcinoma

Showing 9951 - 9975 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Paclitaxel plus 5-fluorouracil, Cisplatin plus 5-fluorouracil, Radiation

Completed
  • Esophageal Squamous Cell Carcinoma
  • Paclitaxel plus 5-fluorouracil
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Cancer Center
Oct 17, 2018

Cervical Cancer = FIGO IIB and or Lymph Node Metastases Trial (Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab),

Not yet recruiting
  • Cervical Cancer ≥ FIGO IIB and or Lymph Node Metastases
  • Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab)
  • +2 more
  • (no location specified)
Aug 16, 2022

Patients With Advanced Metastatic Colorectal Cancer Trial in Wuhan (Tislelizumab plus Fruquintinib and SBRT)

Active, not recruiting
  • Patients With Advanced Metastatic Colorectal Cancer
  • Tislelizumab plus Fruquintinib and SBRT
  • Wuhan, Hubei, China
    Huazhong University of Science and Technology
Aug 15, 2022

Cervical Cancer Trial in Guangzhou (Type B resection or type C resection of the anterior leaf of vesicouterine ligament during

Recruiting
  • Cervical Cancer
  • Type B resection or type C resection of the anterior leaf of vesicouterine ligament during the radical hysterectomy (type C)
  • Guangzhou, Guangdong, China
    Huaiwu Lu
Jun 14, 2023

End Stage Renal Disease, Hemodialysis Trial in Clermont-Ferrand (Chlorhydric acid based acid concentrate for bicarbonate

Recruiting
  • End Stage Renal Disease
  • Hemodialysis
  • Chlorhydric acid based acid concentrate for bicarbonate hemodialysis (medical device)
  • Clermont-Ferrand, France
    CHU de Clermont-Ferrand
Feb 28, 2022

CT Perfusion Parameters for Advanced HCC Treated by Systemic

Completed
  • Advanced HCC Treated by Systemic Immunotherapy
    • Nancy, France
      CHRU Nancy
    Oct 13, 2022

    Advanced Cancer Trial in Beijing, Tianjin (CM082 Tablet)

    Completed
    • Advanced Cancer
    • CM082 Tablet
    • Beijing, Beijing, China
    • +2 more
    Jul 2, 2019

    Advanced Solid Tumors Cancer Trial in Worldwide (Osimertinib, Nivolumab, Telisotuzumab vedotin)

    Recruiting
    • Advanced Solid Tumors Cancer
    • Scottsdale, Arizona
    • +35 more
    Jan 12, 2023

    Polycystic Kidney Disease, Adult Trial in Bethlehem (Lixivaptan)

    Active, not recruiting
    • Polycystic Kidney Disease, Adult
    • Bethlehem, Pennsylvania
      Northeast Clinical Research Center, LLC
    Jun 7, 2022

    Pancreatic Ductal Adenocarcinoma Trial in Philadelphia (mDC3/8-KRAS Vaccine)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • mDC3/8-KRAS Vaccine
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Apr 4, 2022

    Acute Myeloid Leukemia Trial in Wuhan (Fludarabine + Cyclophosphamide + TAA05 Cell Injection)

    Recruiting
    • Acute Myeloid Leukemia
    • Fludarabine + Cyclophosphamide + TAA05 Cell Injection
    • Wuhan, Hubei, China
      Wuhan Union Hospital
    Jun 29, 2022

    Advanced/Metastatic Solid Tumors Trial in Kurralta Park, Clayton (ADG206)

    Not yet recruiting
    • Advanced/Metastatic Solid Tumors
    • Kurralta Park, South Australia, Australia
    • +1 more
    Nov 9, 2022

    Sarcoma Trial in Guangzhou (Fluzoparib+ Dalpiciclib)

    Recruiting
    • Sarcoma
    • Fluzoparib+ Dalpiciclib
    • Guangzhou, Guangdong, China
      Cancer Center of Sun-Yat Sen University (CCSYSU)
    Jul 11, 2023

    A Nationwide Multicenter, Ambispective Real-world Study of

    Recruiting
    • Breast Cancer
      • Zhengzhou, Henan, China
        Henan cancer hospital
      Sep 15, 2022

      DLBCL, DLBCL Germinal Center B-Cell Type, DLBCL, Not Otherwise Specified Trial in Columbus (Molecular Nanotechnology)

      Recruiting
      • Diffuse Large B-Cell Lymphoma
      • +3 more
      • Molecular Nanotechnology
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Jun 2, 2022

      Adult Solid Tumor Trial (LTC004)

      Not yet recruiting
      • Adult Solid Tumor
      • LTC004
      • (no location specified)
      Dec 18, 2022

      Renal Colic Trial (0.9% Sodium-chloride, Placebos, Optalgin, Voltaren, Morphine)

      Withdrawn
      • Renal Colic
      • 0.9% Sodium-chloride
      • +2 more
      • (no location specified)
      Sep 27, 2021

      Applications of MRI in Kidney Disease

      Not yet recruiting
      • Chronic Kidney Disease
      • End-stage Kidney Disease
      • No intervention but only observational
      • Minneapolis, Minnesota
        University of Minnesota Medical Center
      Mar 28, 2022

      New Fixed-dose Nivolumab Regimen With Old mg/kg Regimen in

      Completed
      • Metastatic Cancer
        • (no location specified)
        May 31, 2022

        Renal Impairment in Non-alcoholic Fatty Liver Disease.

        Not yet recruiting
        • Non-Alcoholic Fatty Liver Disease
        • serum Adiponectin
        • (no location specified)
        Oct 23, 2021

        Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

        Not yet recruiting
        • Refractory Leukemia
        • +4 more
        • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
        • Dendritic Cell Vaccine
        • Miami, Florida
          University of Miami
        Jan 23, 2023

        Chemo, Colorectal Cancer, Intestinal Mucositis Trial (Losartan 50mg Tab)

        Not yet recruiting
        • Chemotherapy
        • +3 more
        • Losartan 50mg Tab
        • (no location specified)
        May 13, 2023

        Carcinoma, Renal Cell Trial in Houston (Sunitinib, Temsirolimus, Sorafenib)

        Terminated
        • Carcinoma, Renal Cell
        • Houston, Texas
          UTHealth Memorial Hermann Cancer Center
        Sep 12, 2018

        Bleeding, Hemoptysis Trial in Zagreb (Tranexamic acid, Adrenaline, Placebo)

        Not yet recruiting
        • Bleeding
        • Hemoptysis
        • Tranexamic acid
        • +2 more
        • Zagreb, Croatia
          University Hospital Centre Zagreb
        Nov 20, 2023

        Spanish Real World Data on Patients Treated With Durvalumab

        Completed
        • Small Cell Lung Cancer (SCLC)
        • Santiago De Compostela, A Coruña, Spain
        • +38 more
        Jun 2, 2022